HemaSphere (Oct 2022)

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers

  • Simonetta Viviani,
  • Anna Vanazzi,
  • Samuele Frassoni,
  • Chiara Rusconi,
  • Andrea Rossi,
  • Alessandra Romano,
  • Caterina Patti,
  • Corrado Schiavotto,
  • Roberto Sorasio,
  • Vincenzo Marasco,
  • Laura Lissandrini,
  • Davide Rapezzi,
  • Daniela Gottardi,
  • Federica Cocito,
  • Antonino Mulè,
  • Guido Gini,
  • Roberta Zanotti,
  • Alessandro Rambaldi,
  • Vincenzo Bagnardi,
  • Corrado Tarella

DOI
https://doi.org/10.1097/01.HS9.0000891008.01210.7b
Journal volume & issue
Vol. 6
pp. 51 – 51

Abstract

Read online

No abstracts available.